Information Links
Mims
Main Navigation
Drugs
Conditions
News and resources
MIMS HostedWomen's health news
HRT and antidepressant shortages prompt export ban and pharmacist scrip-switching
The government has banned exports of HRT products and...
Low-dose oestrogen pessary for vaginal menopause symptoms
Imvaggis (estriol) is a new treatment for vaginal symptoms...
Discuss new information on HRT breast cancer risk with women at next routine appointment, MHRA advises prescribers
Prescribers have been advised to discuss the risk of...
Contraceptive shortages reported by manufacturers
Shortages of several contraceptives, including combined,...
New low-dose oestrogen gel for vaginal menopause symptoms
Blissel is a topical gel containing 50 microgram/g...
HRT shortages set to continue, manufacturers confirm
Several widely prescribed brands of HRT will remain...
New non-oestrogen treatment for vaginal menopause symptoms
Intrarosa (prasterone) is a new topical treatment for...
Refresh your knowledge on prescribing in pregnancy with MIMS Learning
MIMS Learning is offering a new interactive module,...
New advice for carbimazole over malformation and pancreatitis risks
Reports of congenital malformations and acute pancreatitis...
New non-hormonal menopause treatment
Prescribers treating postmenopausal women with vulvar...
New pregnancy prevention measures for retinoid products
Further restrictions have been announced on the use...
New morning sickness treatment available for women in the UK
GPs can now prescribe the combination treatment Xonvea...
Prescribe contraception confidently with new MIMS tables
Prescribers can quickly check how to start combined...
Doctors identify 50 'unnecessary' medical interventions
A list of 50 tests, treatments and procedures 'of questionable...
Antibiotics effective for chronic urinary symptoms even when UTI tests negative
Antibiotics can relieve chronic lower urinary tract...
Do not start any new course of ulipristal for fibroids, MHRA advises
New temporary safety measures have been introduced...
Advise women to take combined contraceptive pills continuously, says family planning expert
The 21/7 contraceptive pill regimen is 'outdated' and...
'No evidence of patient safety risk' with controversial sterilisation device, says MHRA
The MHRA has advised women who have undergone hysteroscopic...
Contraceptive eligibility criteria updated for 2016
The UK Medical Eligibility Criteria for Contraceptive...
Oestrogen/bazedoxifene: first tissue-selective oestrogen complex to treat menopausal symptoms
Duavive (oestrogen/bazedoxifene) is the first menopause...
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
